# Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events

> **NCT05313620** · PHASE4 · RECRUITING · sponsor: **Fundación de Investigación Biomédica - Hospital Universitario de La Princesa** · enrollment: 30 (estimated)

## Conditions studied

- Ulcerative Colitis
- Thromboembolism

## Interventions

- **DRUG:** Tofacitinib
- **DRUG:** Infliximab Adalimumab y Golimumab

## Key facts

- **NCT ID:** NCT05313620
- **Lead sponsor:** Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05313620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05313620, "Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05313620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*